Cytely

Cytely

Private
LundHealthcare & Life Scienceshttps://www.cytely.io/

Last Round

Seed

Oct 23, 2025

Total Funding Raised

$3.5M

Momentum Score

75 /100

Company Overview

Cytely is a life sciences tool company that provides a smart microscopy software platform to automate real-time analysis and data capture for biomedical research.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

smart microscopyAI microscopyautomated microscopyAI image analysisbio-imaging AIhigh-content screeningmicroscopy softwarelab automationimage cytometrySaaS platformreal-time analysisdrug discovery toolssingle-cell analysisassay analysishardware-agnostic software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytely Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cytely Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 23, 2025
Pre SeedFeb 1, 2024

Key People

Founding team and executive leadership

Aieza Bergante

Operations Manager - CEO Office

Executive Team

Philip Nordenfelt

Co-Founder And CEO

Founding Team

Oscar André

Chief Product Officer

Executive Team

Cytely Investors

Notable investors and investment history

InvestorRounds
Ugly Duckling VenturesSeed
Icebreaker.vcSeed, Pre Seed
SmiLe Venture HubSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 108% MoM.

  • Apr 17, 2026

    Grew 27% QoQ, from 15 to 19 employees.

Cytely Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cytely Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytely's valuation, stock price, and market status.

Firmographic Details

HeadquartersLund
Employee Range19
Year Founded2022
Last FundingOct 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.